2022 Senate Bill 1171

Revise opioid antagonist regulation detail

Introduced in the Senate

Sept. 20, 2022

Introduced by Sen. Curtis VanderWall (R-35)

To establish that an employee of a government agency authorized to obtain and distribute an opioid antagonist (naloxone) may “distribute” naloxone, in addition to “administer” it.

Referred to the Committee on Health Policy and Human Services

Nov. 29, 2022

Reported without amendment

With the recommendation that the bill pass.